The nurse portal is your access point for information and resources that can help you effectively care for patients throughout BAVENCIO treatment.
Providing your patients with a clear understanding of what to expect during BAVENCIO maintenance treatment and what to do in certain situations can help them be better prepared.
Before treatment, it may be helpful to discuss with your patients:
What BAVENCIO maintenance treatment is and how it can help
How they will receive BAVENCIO
The importance of reporting adverse reactions
Who to call if they experience signs or symptoms of adverse reactions
BAVENCIO is administered as an 800 mg IV infusion over 60 minutes every 2 weeks.
|Grade 1-2||Grade 3-4|
|Interrupt or slow the rate of infusion||Stop the infusion and permanently discontinue BAVENCIO|
|Interrupt or slow the rate of infusion|
|Stop the infusion and permanently discontinue BAVENCIO|
Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue and at any time after starting treatment, or after discontinuation.
Discuss the importance of reporting any signs or symptoms of immune-mediated adverse reactions as soon as they occur
Other downloadable resources to assist you in your practice